[{"id":"50e95443-c92c-48dc-b638-e94294dd906a","acronym":"KEYNOTE-A72","url":"https://clinicaltrials.gov/study/NCT03260322","created_at":"2021-01-18T16:06:27.240Z","updated_at":"2025-02-25T16:06:46.737Z","phase":"Phase 1","brief_title":"A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT03260322 - KEYNOTE-A72","lead_sponsor":"Astellas Pharma Global Development, Inc.","biomarkers":" EGFR • ALK","pipe":" | ","alterations":" EGFR mutation • ALK positive • ALK mutation","tags":["EGFR • ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • ALK positive • ALK mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • ASP8374"],"overall_status":"Completed","enrollment":" Enrollment 169","initiation":"Initiation: 09/08/2017","start_date":" 09/08/2017","primary_txt":" Primary completion: 05/10/2022","primary_completion_date":" 05/10/2022","study_txt":" Completion: 05/10/2022","study_completion_date":" 05/10/2022","last_update_posted":"2024-11-13"},{"id":"d40a4c4a-7ae7-48b2-b819-a244a5ef19c7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03945253","created_at":"2021-01-18T19:25:31.128Z","updated_at":"2024-07-02T16:36:29.803Z","phase":"Phase 1","brief_title":"Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT03945253","lead_sponsor":"Astellas Pharma Inc","biomarkers":" EGFR • ALK","pipe":" | ","alterations":" EGFR mutation • ALK positive • ALK mutation","tags":["EGFR • ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • ALK positive • ALK mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ASP8374"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 08/05/2019","start_date":" 08/05/2019","primary_txt":" Primary completion: 06/12/2020","primary_completion_date":" 06/12/2020","study_txt":" Completion: 06/12/2020","study_completion_date":" 06/12/2020","last_update_posted":"2021-05-25"}]